Company identity
Company number 11535661
Company profile
UK company 11535661, incorporated on 24 August 2018.
Abtrace - Transforming Clinical Decisions through Data
Transforming Clinical Decisions through Data
Company number 11535661
Financial period: 1 Sep 2023 to 31 Aug 2024
Reference milestones and recent Companies House filing stream events.
CS01 | Transaction MzU0MjM0Nzk4NmFkaXF6a2N4
Published 03 Sep 2026 09:41
Company registered at Companies House
1 Mar 2024 to 31 Aug 2025
**BACKGROUND** Every year over **40% of the UK population take 770 million regular medications** to manage and prevent disease. Their General Practitioner (GP) has the vast task of ensuring they are on the right medications, **with 15% of the population taking more than 5 medications regularly, and 25% having multiple long-term conditions.** **PROBLEM** I...
1 Nov 2023 to 31 Jul 2025
More than a thousand patients are diagnosed with cancer daily in the UK - **1 in 2 people will get this diagnosis in their lifetime**. Many cancers being diagnosed at an advanced stage when treatments are less effective. The UK has poorer cancer survival rates compared to other high-income countries. The long-term plan aims to be diagnosing 75% of cancer ...
1 Aug 2023 to 31 Jan 2025
The **NHS and health systems around the world are under great pressure** with rising A&E attendances and hospital admissions alongside **budgetary pressures,** backlogs and an increasingly **ageing, less healthy population**. Hospitals are overflowing. However, **1 out of 5** emergency admissions are **avoidable** and responsible for taking up 13% of all ...
1 Oct 2022 to 31 Mar 2024
In addition to _treating_ disease, healthcare staff in primary care try to _prevent_ disease. Patients who meet clinical risk criteria can benefit from actions like starting medications before they develop a disease. These _preventative interventions_ reduce the risk of disease or delay it. **40% of all yearly deaths are thought to be due to preventable c...
1 Dec 2021 to 31 Jan 2022
**Challenge to address** At every stage of the Patient inflow and outflow process within the NHS, there are delays which impact on patient care, staff, hospital resources and efficiency. The vast majority of delays are attributable to hospitals and staff not having access to information or that information being incomplete or out-of-date, which in turn le...
1 Jul 2021 to 30 Jun 2023
UK cancer survival rates lag behind other developed countries(1), up to 10,000 excess deaths occur annually in comparison(2). Delayed diagnosis is thought to contribute to this(3). Currently nearly half of all cancers are diagnosed at a late stage(4). Approximately 20% of patients see their GP 3 or more times before their cancer diagnosis(7) with approxim...
1 Nov 2020 to 30 Apr 2022
**Challenge to address** At every stage of the Patient inflow and outflow process within the NHS, there are delays which impact on patient care, staff, hospital resources and efficiency. The vast majority of delays are attributable to hospitals and staff not having access to information or that information being incomplete or out-of-date, which in turn le...